Moving your product successfully towards market hinges on the talents of those developing it. Our scientist and professionals are among the top in the industry. We combine our experience and expertise to become an extension of your company, helping to overcome challenges and develop solutions to provide the most effective path towards success for your product.
Working for Progen Pharmaceuticals for 11 years prior to becoming CEO of LuinaBio (previously PharmaSynth) in 2009. During his time at Progen, Les has worked with and overseen Progen’s anti-cancer drug PI-88s progression from preclinical to phase 3 manufacture.
He has also been responsible for the tech transfer and manufacture of many client products for both clinical applications and marketed products. Les holds a Bachelor of Science in microbiology and a Bachelor of Engineering in Chemical Engineering.
Prior to commencing with Progen, Les spent 11 years working in clinical pathology for Drs Sullivan and Nicolaides Pathologists and has worked on various research projects for both the Department of Primary Industries and the University of Queensland.
Graeme joined Luina Bio in 2005 (then Progen) as Quality Assurance Manager/Director Quality, with responsibility for all quality assurance and quality control functions. During this time he was responsible for the development and validation of procedures supporting the phase III manufacture of PI-88. In 2015 Graeme moved into the role of Operations Manager, overseeing the internal operations of Luina Bio including production, warehousing and logistics, and facility management.
Prior to working for Luina Bio, Graeme was Site Manager for a large analytical services company, managing 3 laboratories.Previous to this, Graeme spent 15 years as Quality Assurance Manager for 2 medium to large pharmaceutical companies, both producing in excess of 100 batches of product per month. In these roles he was responsible for all quality assurance, quality control and regulatory issues.
Graeme has nearly 40 years pharmaceutical industry experience. He holds a BAppSc (Hons) in chemistry from the New South Wales Institute of Technology.
Tina joined Luina Bio in November 2016 as Quality Manager, with responsibilities for Quality Control and Quality Assurance. Our Quality Management System is designed to ensure compliance standards meets the high expectations of regulators and clients, and is undergoing continuous improvements to ensure it meets new and emerging trends. Tina has previously held Quality Manager positions with several Australian and Multinational Pharmaceutical GMP manufacturers.
Prior to joining Luina Bio, Tina was QA Manager at Patheon Biologics (previously DSM Biologics) for >4 years, playing an instrumental role in the start-up team for the new Brisbane state-of-the art facility, and successful grant of the GMP Licence in early 2014 for manufacture of drug substances in mammalian cell cultures.
Her experience also includes being QA Manager at local Brisbane based GMP manufacturing facilities for >6 years.
Her experience covers a wide range of solid and liquid dosage forms, and includes clinical as well as commercial manufacturing and biotechnology. Prior to emigrating to Australia, Tina was a Qualified Person (QP) in a large multinational pharmaceutical company in Denmark. Tina has a Ms.Sc in Pharmacy.
Head, Business Development
Max graduated with a BSc at Latrobe University, MSc at UWA, MSc at Universita’ La Sapienza, Roma and MBA at NIMBAS (UK).
During a career spanning over 20 years, Max successfully led business development into both emerging and established global markets for three multinational pharmaceutical services organizations and several smaller firms.
Working as the lead sales manager or manager of a sales team in territories from the Asia Pacific to Southern Europe, Max created stable and fruitful relationships with customers and internal teams.
Lately he has been invited to join the board of two biotechnology companies in Australia.
Mr Anthony Jay
Anthony has been with LuinaBio since the company’s commencement in 2008. Prior to moving into the Production Supervisor role in 2015 he held roles as Facility Supervisor and Scientist, overseeing technology transfer and manufacturing in both upstream and downstream processing on a variety of projects.
He has been responsible for producing API for local and international clients for applications from preclinical use to phase 3 clinical trials. Anthony holds a Bachelor of Science in Microbiology and Biology and a Masters in Environmental Economics.
Anthony holds a Bachelor of Science in Microbiology and Biology and a Masters in Environmental Economics.
Dr Bin Wang
Scientist Dr Bin Wang has been a senior Bioprocessing scientist for 20 years. Bin’s field of expertise is in fermentation process and during this time, he has been responsible for the aerobic and anaerobic fermentations of a wide variety of organisms. These have included recombinant E.coli, Pichia, Pseudomonas, Serratia, Streptomyces and many others.
Bin has skills in bioreactions from small scale development in shake flasks or small fermenters through to large scale production fermenters. Bin has a Bachelor of Food and Fermentation Engineering from the Tianjin Institute of Light Industry, and a Master of Microbiology from the Beijing Agriculture University. In 1993, He was awarded a Ph.D in Biotechnology from the University of New South Wales, Sydney.
Dr. Jason Ryan
Senior Bioprocessing Scientist
Dr Jason Ryan is a Senior Bioprocessing scientist at LuinaBio joining in 2016. Previously Jason was a Principal Scientist at Callaghan Innovation, New Zealand. His field of expertise is in fermentation and has been responsible for the development and optimization of fermentation systems for recombinant E.coli, fungi, yeasts, marine microorganisms, extremophiles, bacteriophage and anaerobes.Jason has over 20 peer reviewed publications on design of experiment, scale up and metabolite production optimization.
Jason has a Bachelor of Science in biotechnology from Griffith university, a Master of Philosophy in Biotechnology from Massey University. In 2012, he was awarded a Ph.D in Chemical and Process Engineering from Canterbury University, New Zealand
Dr. Nicolas Paquet
Senior Bioprocessing Scientist
Dr. Nicolas Paquet holds a Senior downstream bioprocessing scientist role in our production team. Building upon his career in medical research, Nicolas has skills in protein expression and chromatography, ranging from early development to large scale production, in addition, his expertise encompasses molecular biology as well as biophysics (Surface Plasmon Resonance, MultiAngleLight Scattering, Circular Dichroism Spectrophotometry).
Nicolas obtained his PhD from the Paris XI University, France, before pursuing his post-doctoral training in Biochemistry at the Department of Molecular Biophysics and Biochemistry at Yale University, USA.As part of his role, Nicolas managed the department’s core facility for protein purification, providing state-of-the-art technical support and training in protein expression and purification, biophysical and biochemical characterization of proteins for various projects across the Yale medical school. Following his relocation to Brisbane, Nicolas continued his academic work on the role of DNA repair proteins in cancer development, before joining LuinaBio in 2016.
Quality Control Manager
Suong is currently a Quality Control Manager at LuinaBio. Prior to this, she joined PharmaSynth in 2012 as a QC Supervisor, which carries responsibility over quality control functions including development and validation of procedures.
Suong spent 12 years working in large pharmaceutical companies in various positions, including Laboratory Assistant Manager. She has extensive knowledge of GMP and significant experience in GLP.
Suong hold a BAppSc in Medical Science from Queensland University of Technology.